Wait, what? Or­a­cle tech founder Lar­ry El­li­son in­vests in­to ex-stealth ge­nomics di­ag­nos­tics biotech

At last count by Bloomberg, Lar­ry El­li­son was worth close to $120 bil­lion, putting him on the top 10 list of the rich­est peo­ple on the plan­et. And he’s shelling out a tiny bit of that to back the launch round of a buzzy di­ag­nos­tic out­fit in Is­rael.

The co-founder, ex-CEO and now CTO of tech gi­ant Or­a­cle Cor­po­ra­tion co-led an $18.5 mil­lion Se­ries A in­to Im­a­gene AI, an on­col­o­gy-fo­cused biotech look­ing to in­te­grate its cus­tom al­go­rithms in­to dig­i­tized ge­nomics and pre­dict cer­tain as­pects of some­one’s can­cer, such as re­sponse to cer­tain ther­a­pies and the pres­ence of cer­tain mu­ta­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER